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Summary
 
Immunoglobulins (Ig), particularly IgE, are believed to be crucially involved in the pathogene-
sis of asthma and, equally, in allergic models of the disease. To validate this paradigm we exam-
ined homozygous mutant C57BL/6 mice, which are B cell deficient, lacking all Ig. Mice were
immunized intraperitoneally with 10 
 
m
 
g ovalbumin (OVA) plus alum, followed by daily (day
14–20) 30 min exposures to OVA aerosol (OVA/OVA group). Three control groups were
run: OVA intraperitoneally plus saline (SAL) aerosol (OVA/SAL group); saline intraperito-
neally plus saline aerosol; saline intraperitoneally plus OVA aerosol (
 
n
 
 
 
5
 
 6–7). Lung and large
airway tissues obtained 24 h after the last OVA or SAL exposure were examined by light mi-
croscopy and transmission electron microscopy (TEM). The Ig-deficient mice receiving OVA/
OVA treatment had swollen and discolored lungs and exhibited marked eosinophilia both in
large airway subepithelial tissue (49.2 
 
6
 
 12.0 cells/mm basement membrane [BM] versus OVA/
SAL control 1.2 
 
6
 
 0.3 cells/mm BM; 
 
P
 
 
 
,
 
0.001), and perivascularly and peribronchially in the
lung (49.3 
 
6
 
 9.0 cells/unit area versus OVA/SAL control 2.6 
 
6
 
 0.6 cells/unit area; 
 
P
 
 
 
,
 
0.001).
The eosinophilia extended to the regional lymph nodes. TEM confirmed the subepithelial and
perivascular localization of eosinophils. Mucus cells in large airway epithelium increased from
1.5 
 
6
 
 0.8 (OVA/SAL mice) to 39.5 
 
6
 
 5.7 cells/mm BM in OVA/OVA treated mice (
 
P
 
,
 
0.001). OVA/SAL mice never differed from the other control groups. Corresponding experi-
ments in wild-type mice (
 
n
 
 
 
5
 
 6–7 in each group) showed qualitatively similar but less pro-
nounced eosinophil and mucus cell changes. Macrophages and CD4
 
1
 
 T cells increased in lungs
of all OVA/OVA-treated mice. Mast cell number did not differ but degranulation was detected
only in OVA/OVA-treated wild-type mice. Immunization to OVA followed by OVA chal-
lenges thus cause eosinophil-rich inflammation in airways and lungs of mice without involve-
ment of B cells and Ig.
 
A
 
irway mucosal inflammation in allergic asthma is char-
acterized by increased numbers of eosinophils, but
macrophages and T and B lymphocytes also may be in-
creased (1, 2). The eosinophils are believed to play a central
role in the pathogenesis of this disease by releasing proinflam-
matory mediators/cytokines and proteins that are epithelium
toxic (3, 4). Eosinophils express various Ig Fc receptors possi-
bly involved in activation of these cells (5, 6). IgE may me-
diate eosinophil recruitment and activation also through in-
direct pathways, i.e., through the release of mast cell mediators/
cytokines (7, 8) and T cell cytokines (9). Coyle and col-
leagues (9) recently reported that administration of non-
anaphylactogenic anti-IgE mAbs (neutralizing serum IgE)
before antigen challenge significantly reduced the recruit-
ment of eosinophils into the lungs of actively immunized
mice. Through further experiments involving anti-CD23
mAbs and CD23-deficient mice, the authors suggested that
this effect was due to inhibition of the IgE–CD23-facili-
tated antigen presentation to T cells, leading to inhibited
secretion of IL-5 (9). Such data agree well with a widely
accepted paradigm that allergic eosinophilic asthma is an
IgE-dependent disease. This paradigm, which also rests on
epidemiological data showing association between elevated
IgE levels and bronchial asthma (10, 11), forms the basis of
major research lines including development of treatment
principles such as anti-IgE and anti–IL-4 (12, 13). How-
ever, there are also reports that question a major role of IgE
in asthma and in allergic models of asthma. For example,
specific IgE titres may not correlate with airway hyperreac-
tivity or pulmonary eosinophilia (14, 15), and anaphylactic
death can occur in IgE-deficient mice (16). In the latter
study, the authors suggested that other Ig than IgE were in-
volved in this anaphylaxis (16).
This study examines whether or not eosinophilic airway
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and pulmonary responses may develop in immunized and al-
lergen-exposed mice in the absence of all Ig. Thus, we have
used mice that are B cell deficient (lacking all Ig) due to a
homozygous targeted disruption of the membrane exon of
the Ig 
 
m
 
 chain gene (17). We used a protocol that in corre-
sponding wild-type mice produces an established allergic
model of eosinophilic asthma (14, 18–20). Hence, this
study asks whether B cells and Ig are crucially involved in
the development of immunization and allergen exposure-
induced eosinophilic pulmonary and airway inflammation.
 
Materials and Methods
 
Animals and Study Design.
 
Homozygous mutant C57BL/6
mice with a targeted disruption of the membrane exon of the Ig 
 
m
 
chain gene (17) (Jackson Laboratory, Bar Harbor, ME), 6–8 mo
of age, and wild-type C57BL/6 mice (Bomholtgaard, Denmark),
3 mo of age, were used in the experiments. The present batch of
Ig-deficient mice was routinely checked for lack of Ig by immu-
nohistochemistry, using FITC-labeled anti-IgG and anti-IgM an-
tibodies. All mice were kept in well-controlled animal housing
facilities and had free access to tap water and pelleted food
throughout the experimental period.
Each experimental group consisted of 6–10 animals. Two groups
of Ig-deficient mice and two groups of wild-type mice were ac-
tively immunized to OVA (day 0). Also, two groups each of the
different mice were sham immunized with saline (SAL)
 
1
 
 (day 0).
From day 14 to day 20, the groups were challenged either with
aerosolized OVA or SAL (Table 1). Animals were sacrificed by
i.p. injection of pentobarbital 24 h after last aerosol challenge, and
the lungs and extrahilar tracheobronchial airways were rapidly
dissected out.
 
Immunization and Challenge.
 
We have used a protocol slightly
modified from that developed by Brusselle and colleagues (20).
On the first day of the experiment (day 0), mice were actively
immunized to chicken OVA (Grade III; Sigma, St. Louis, MO)
via i.p. injection with 10 
 
m
 
g OVA, adsorbed to 1 mg of alum.
Control animals were injected i.p. on day 0 with 0.4 ml SAL.
From day 14 to day 20, the mice were exposed daily to aerosolized
SAL or OVA over a 30-min period by placing groups of 6–12 awake
mice in an exposition chamber. The aerosols were generated into
the chamber using a nebulizer (Bird 500 ml Inline Micronebu-
lizer driven at 4 bar, Bird Co., Palm Springs, CA). The concen-
tration of OVA in the nebulizer was 1% wt/vol. Immunized
wild-type mice were required to develop inflammatory infiltrates
after allergen challenge to be included in the present analysis.
 
Histochemistry.
 
Lung tissue specimens and extrahilar large air-
way segments were immersed overnight in Stefanini’s fixative
(2% paraformaldehyde and 0.2% picric acid in 0.1 M phosphate
buffer, pH 7.2), rinsed repeatedly in buffer (Tyrode buffer supple-
mented with 10% sucrose), frozen in mounting medium (Tissue-
Tek, Miles, Inc., Elkhart, IN), and stored at 
 
2
 
80
 
8
 
C until section-
ing. Eosinophils were detected by histochemical visualization of
cyanide-resistant eosinophil peroxidase (EPO) activity (21). In brief,
10-
 
m
 
m cryosections were incubated for 8 min at room tempera-
ture in PBS buffer (pH 7.4) supplemented with 3.3-diaminoben-
zidine tetrahydrochloride (60 mg/100 ml; Sigma), 30% H
 
2
 
O
 
2
 
(0.3 ml/100 ml), and NaCN (120 mg/100 ml). Slides were then
rinsed in water and mounted in Kaisers medium (Merck, Darm-
stadt, Germany). Eosinophils were identified by their dark brown
reaction product. For histochemical detection of mucus-contain-
ing cells in lungs and airways, 10-
 
m
 
m cryosections were stained
with periodic acid–Schiff reagent (PAS). Distinct purple–red
granules could be observed in the mucus-containing cells. For as-
sessment of general airway morphology, sections were stained
with hematoxylin and erythrosin. Also, toluidine blue staining
was performed to visualize mast cells.
 
Immunohistochemistry.
 
Lung tissue specimens were rapidly fro-
zen on dry ice in mounting medium and stored at 
 
2
 
80
 
8
 
C until
sectioning. 10-
 
m
 
m specimens were cut in a cryostat and the sec-
tions placed on chromealum-coated slides and air-dried. To visu-
alize macrophages, sections were fixed in cold acetone diluted 1:2
 
1
 
Abbreviations used in this paper: 
 
BAL, bronchoalveolar lavage fluids; Cfegs,
clusters of free eosinophil granules; EPO, eosinophil peroxidase; PAS, pe-
riodic acid–Schiff reagent; SAL, saline; TEM,
 
 
 
transmission electron mi-
croscopy.
 
Table 1.
 
Effects on Eosinophils and Mucus Cells of Immunization and Allergen Challenge in Ig-Deficient and Wild-type Mice
 
Groups Immunization Challenge
Eosinophils in lung tissue
(eos./unit area)
Eosinophils in large
airway subepithelial
tissue (eos./mm BM)
Mucus cells in large
airway epithelium
(cells/mm BM)
Ig-deficient OVA/OVA OVA OVA 49.3 
 
6
 
 9.0
 
*
 
49.2 
 
6
 
 12.0
 
*
 
§
 
39.5 
 
6
 
 5.7
 
*
 
§
 
Ig-deficient OVA/SAL OVA SAL 2.6 
 
6
 
 0.6 1.2 
 
6
 
 0.3 1.5 
 
6
 
 0.8
Ig-deficient SAL/OVA SAL OVA 3.4 
 
6
 
 0.6 1.0 
 
6
 
 0.3 0.3 
 
6
 
 0.2
Ig-deficient SAL/SAL SAL SAL 3.7 
 
6
 
 0.8 1.0 
 
6
 
 0.4 0.6 
 
6
 
 0.3
Wild-type OVA/OVA OVA OVA 30.2 
 
6
 
 10.2
 
*
 
12.2 
 
6
 
 5.8
 
‡
 
29.3 
 
6
 
 6.2
 
§
 
Wild-type OVA/SAL OVA SAL 1.5 
 
6
 
 0.9 0.9 
 
6
 
 0.4 4.7 
 
6
 
 2.7
Wild-type SAL/OVA SAL OVA 1.0 
 
6
 
 0.2 0.9 
 
6
 
 0.4 2.4 
 
6
 
 1.3
Wild-type SAL/SAL SAL SAL 1.4 
 
6
 
 0.2 0.9 
 
6
 
 0.4 0.4 
 
6
 
 0.2
BM, basement membrane; values are means 
 
6
 
 SEM.
 
*
 
P
 
 
 
,
 
0.001 compared with the corresponding OVA/SAL control group.
 
‡
 
P
 
 
 
,
 
0.01.
 
§
 
P
 
 
 
,
 
0.05. 
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in distilled water for 30 s, followed by final fixation in cold ace-
tone (100%) for 5 min. After washing in PBS supplemented with
0.25% Triton X-100, the sections were exposed to a monoclonal
rat anti–mouse F4/80 antigen antibody (code no. MCA 497; Se-
rotec, Kidlington, UK) overnight at 
 
1
 
4
 
8
 
C. Next, after washing,
the sections were incubated with a FITC-labeled affinity-purified
anti-rat Ig secondary antibody raised in rabbit (Vector Laborato-
ries, Burlingame, CA) 1 h at room temperature. After another
washing, the sections were mounted in PBS/glycerine (1:1) and
examined in a fluorescence microscope. To visualize CD4
 
1
 
 T
cells, unfixed tissue sections were exposed to a rat monoclonal
anti–mouse L3T4 (CD4) antibody (code no. 01440; Becton
Dickinson, Bedford, MA) for 1 h at room temperature, washed,
and then incubated for 1 min with the same secondary antibody
as above. After another washing, the sections were mounted as
above and examined. In control sections, omitting the primary
antibody, no or only slight background staining was found.
 
Transmission Electron Microscopy.
 
Lung tissue and proximal
tracheal segments were immersed in a fixative consisting of a
mixture of 3% formaldehyde and 1% glutaraldehyde in 0.1 M
phosphate buffer, pH 7.2. The specimens were fixed overnight
and then post fixed in 1% osmium tetroxide for 1 h. Then, they
were dehydrated in graded acetone solutions, and embedded in
Polybed 812 (Polysciences, Inc., Warrington, NY). For high res-
olution light microscopy, semithin (1 
 
m
 
m) sections of the embed-
ded tissue were cut and stained with Azur–methylene blue. These
sections were used to select areas of interest for electron micro-
scopical examination. Ultrathin sections (60–80 nm) were cut on
an LKB MK III ultratome and routinely contrasted with uranyl
acetate and lead citrate. The sections were examined using a Phil-
ips CM-10 transmission electron microscope.
 
Quantification and Statistics.
 
Quantification of eosinophils, mast
cells, or PAS-positive cells in the extrahilar airways was performed in
one section from each animal. The total number of eosinophils or
mast cells within 0–120 
 
m
 
m from the airway epithelial basement
membrane and the total number of PAS-positive cells in the large
airway epithelium in each section were counted. The total length
of the airway epithelial basement membrane in each section was
calculated using a computerized image analysis system and the
density of eosinophils, mast cells, or PAS-positive cells was ex-
pressed as cells/mm basement membrane. For evaluation of the
number of eosinophils in pulmonary tissue, ten randomly selected
areas (0.04 mm
 
2
 
 each) in one lung section from each animal were
examined. The number of eosinophils in the 10 areas was
Figure 1. Lung histology.
Eosinophils are visualized by his-
tochemical demonstration of cy-
anide-resistant eosinophil peroxi-
dase activity. Multifocal perivascular
and peribronchial eosinophilic
distribution in the lung tissue is
seen in immunized and OVA-
challenged Ig-deficient (a) and
wild-type (b) mice. No eosino-
philic infiltrates were observed in
lung tissue from control mice of
either the Ig-deficient (c) or the
wild-type (d) mice. B, bronchus;
V, blood vessel. Bar, 60 mm. 
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counted at a magnification of 
 
3
 
400 and the mean was expressed
as eosinophils/unit area. All quantifications were performed in a
blind fashion.
Data are expressed as mean 
 
6
 
 SEM. To calculate significance
levels between treatment groups Student’s 
 
t
 
 test was used through-
out the study. To achieve comparable standard deviations, values
were transformed to logarithms before the statistical analysis. 
 
P
 
 
 
,
 
0.05
were used as the generally accepted level of statistical significance
for differences between mean values. In no case were significan-
ces between corresponding control groups, i.e., SAL/SAL, SAL/
OVA, and OVA/SAL, obtained.
 
Results
 
Eosinophils.
 
On gross examination during the tissue dis-
section, the lungs of OVA/OVA-treated animals appeared
swollen and discoloured. These animals, of both the Ig de-
ficient and wild type, showed a multifocal perivascular and
peribronchial eosinophilic distribution in the lung tissue
(Fig. 1, 
 
a–b
 
) and marked eosinophilic infiltrates occurred in
the large airway tissue and in the tracheobronchial lymph
nodes (Table 1). There was a particularly dense infiltration
of eosinophils in the tracheobronchial lymph nodes of Ig-
deficient mice (Fig. 2). Eosinophilic infiltrates were not ob-
served in lung or large airway tissue from control mice of
either the wild-type or the Ig-deficient type (Fig. 1, c–d;
Table 1).
Ultrastructural examination confirmed the infiltration of
eosinophils in the subepithelial tissue of the trachea, bron-
chi, and bronchioles and around smaller vessels in immu-
nized and OVA-challenged mice. Also, to a much lesser
extent, eosinophils were observed in the alveolar walls.
Very few eosinophils were detected in the airway epithe-
lium. Ultrastructural signs of activation/degranulation of
eosinophils were not found in the lung or large airway tis-
sue of OVA/OVA-treated mice, i.e., the secondary gran-
ules had a central electron-dense core surrounded by a
lighter area and clusters of free extracellular eosinophil
granules (as would occur secondary to eosinophil lysis) were
not detected. Numerous lymphocytes, macrophages, and a
few neutrophils were seen both in large airways and lungs
of OVA/OVA-treated mice.
Epithelial Changes. In OVA/OVA-treated animals (both
B cell–deficient and wild-type mice) there was a marked
increase in airway epithelial mucus cells (Table 1) and the
height of the epithelium appeared to be increased (Fig. 3).
The OVA/OVA-treated animals further differed from
controls by partial or seemingly complete occlusion of
many smaller airways with viscid PAS-positive mucus plugs
(Fig. 4). TEM examination of SAL/SAL-treated animals
revealed only few cells containing mucus granules (see Fig. 3
a), whereas OVA/OVA-treated mice (both B cell deficient
and wild type) exhibited an epithelium with numerous
mucus granule–containing cells protruding into the airway
lumen (see Fig. 3 b).
Immunocytochemistry. Macrophages partly had a peri-
bronchial and perivascular distribution, partly a homogenous
distribution throughout the lung parenchyma in both the
wild-type and Ig-deficient OVA/OVA-treated mice. In the
control mice (OVA/SAL groups), macrophages appeared
less prominent and only the homogenous distribution pat-
tern was observed. CD41 T cells were found mainly accu-
mulated in the peribronchial and perivascular inflammatory
infiltrates of OVA/OVA-treated animals. In control mice
(OVA/SAL groups), CD41 T cells were scarce. No obvi-
ous difference in CD41 T cell distribution pattern was de-
tected between wild type and Ig-deficient mice.
Mast Cells. There was no significant difference in the
number of large airway subepithelial mast cells between
OVA/OVA-treated wild-type and Ig-deficient mice (data
not shown). Furthermore, there was no difference in mast
cell number between OVA/OVA-treated animals and con-
trols (data not shown). In the OVA/OVA-treated wild-
type mice a proportion of the mast cells were degranulated,
i.e., the cells contained only a few metachromatic granules.
This sign of mast cell activation was not detected in the
OVA/OVA-treated Ig-deficient mice or in controls.
Discussion
This study demonstrates that B cell–deficient mice,
when subjected to an immunization and allergen challenge
regime, previously established in wild-type mice (14, 18–20),
develop airway and pulmonary eosinophilic inflammation
and epithelial phenotypic changes at least as pronounced as
in wild-type mice. These data support the notion that B
cells are not essential for antigen presentation in the airways
(22). Furthermore, they indicate that major characteristic
features of allergic mouse models of asthma can develop in-
dependent of all Ig. Thus, the present findings challenge
the general notion that IgE, or other Ig, is crucially in-
volved in the eosinophilic inflammation of allergic airway
disease.
Figure 2. Light micrograph, demonstrating the dense infiltration of
eosinophils in tracheobronchial lymph nodes of OVA/OVA-treated B cell–
deficient mice. Eosinophils are detected by histochemical visualization of
cyanide-resistant eosinophil peroxidase activity. TL, tracheal lumen; LN,
lymph node. Bar, 150 mm.889 Korsgren et al.
The present mice with a homozygous targeted disrup-
tion of the membrane exon of the Ig m chain gene have al-
ready been used in several studies (22–27). They are unable
to produce antibodies and the absence of Ig-positive cells
and Ig deposition has been repeatedly demonstrated (17,
this study). By the use of this knockout mouse, Epstein et al.
(22) have shown that B cells are not critical for the priming
of T cells in response to protein antigen. The present al-
lergic inflammation thus may involve T cell responses (both
priming and secondary responses of T cells) potentially
evoked by involvement of airway dendritic cells (28), mon-
ocytes/macrophages (29), and eosinophils (30, 31) (but not
B cells) as antigen-presenting cells. Using allergic C57BL/6
mice, Kips et al. (18) and Brusselle et al. (19, 20) have dem-
onstrated that eosinophilic pulmonary inflammation and
increased IgE levels do not develop in IL-4–deficient mice
or in mice lacking CD41 T lymphocytes. Other findings,
including the demonstration that allergen-induced pulmo-
nary eosinophilia can be transferred to naive rats by aller-
gen-specific CD41 T cells from sensitized animals (32),
suggest a crucial role of CD41 T cells, and their production
of IL-4 and IL-5 (33), in causing airway and pulmonary
eosinophilia. This study also showed that CD41 T cells and
macrophages were increased by immunization and allergen
exposure both in B cell–deficient and wild-type mice.
In allergic guinea pigs, eosinophils may abound in tra-
cheobronchial lymph nodes (34). An intriguingly dense in-
filtration of eosinophils into the tracheobronchial lymph nodes
was now observed in OVA/OVA-treated mice, being espe-
cially pronounced in the B cell–deficient mice. In a previ-
ous study, Krinzman et al. (35) observed an expansion of the
CD41 T cell population in the tracheobronchial lymph nodes
after antigen challenge in immunized mice. As eosinophils
may have a capability to function as antigen-presenting
cells (30, 31), and because they occur in the regional lymph
nodes in allergic airway inflammation, it cannot be ex-
cluded that these cells are important for T cell activation
in response to protein antigen in the present mice. CD41
T cells also produce IL-4, which may cause excessive IgE
synthesis by B cells (36). IgE antibodies bound to mast cells
typically react with antigen to evoke mast cell degranula-
tion, which, as supported by the present observations, prob-
ably occurred in the wild-type C57BL/6 mice. Release of
proinflammatory mast cell mediators, including eosinophilic
chemotactic factors (7, 8), thus may elicit eosinophilic in-
flammation. However, unreduced levels of eosinophilia in
mast cell–deficient mice (9, 20) and in Ig-deficient mice (this
study) compared with wild-type animals indicate that the
T cells may not rely on this pathway to exert their effects
on airway eosinophilia. The present data are compatible
Figure 4. Light micrographs
of PAS-stained lung tissue cryo-
sections obtained from immu-
nized Ig-deficient mice 24 h
after last challenge with aero-
solized SAL (a) or OVA (b). Af-
ter saline challenge, there are no
PAS-positive cells in the airway
epithelium or PAS-positive ma-
terial in the bronchial lumen. In
contrast, after ovalbumin challenge
there are numerous PAS-positive
cells in the airway epithelium and
PAS-positive material is present in
the bronchial lumen. B, bronchus.
Bar, 100 mm.
Figure 3. Transmission elec-
tron micrographs showing the
tracheal epithelium in Ig-deficient
mice. The tracheal epithelium in
SAL/SAL-treated animals (a) har-
bored only few scattered cells
containing mucus granules. In
contrast, OVA/OVA-treated
mice (b) exhibited an epithelium
with numerous mucus granule–
containing cells (arrows), often
protruding into the airway lu-
men. Bars, 10 mm.890 Immunization and Allergic Inflammation in B Cell–deficient Mice
with a significant role of CD41 T cells but indicate that
neither IgE nor other Ig, or B cells, are required for devel-
opment of eosinophilic inflammation in lungs and airways
of allergic mice.
The present protocol for immunization and allergen ex-
posure was adopted from Kips et al., and Brusselle et al.,
(14, 18–20). In wild-type C57BL/6 mice these authors
have quantitated several features, including increased total
and antigen-specific IgE levels, pulmonary hyperrespon-
siveness, and increased numbers of lymphocytes and eosin-
ophils in bronchoalveolar lavage fluids (BAL). Interestingly,
Kips et al. (14) observed that administration of IL-12, selec-
tively during the challenge period, inhibited both the eosin-
ophilia and the hyperresponsiveness without reducing IgE.
This latter finding may be explained by the possibility,
demonstrated here, that airway and pulmonary inflammation
is Ig-independent in these mice. The present study, which
quantitates eosinophils in airway-pulmonary tissues rather
than in BAL (see references 14, 18–20), demonstrates that
eosinophilic inflammation may be even more pronounced
in mice lacking all Ig than in the wild-type mice. Further
comparisons involving age-matched groups of mice are war-
ranted to validate this particular point of exaggerated eosin-
ophilia. The present focus on eosinophils in the tissues (air-
way, pulmonary, lymph node) further revealed a paucity of
epithelial eosinophils, equally in Ig-deficient and wild-type
mice groups. This is remarkably different from human al-
lergic airway diseases in which eosinophils characteristically
are present in quite large numbers in the epithelium (4).
Another feature of the human diseases (asthma and allergic
rhinitis) is the occurrence of eosinophil lysis and the distri-
bution of clusters of free eosinophil granules (Cfegs) in the
airway mucosa (37). This sign of ultimate activation of eosin-
ophils was not detected in the present study, in any group
of animals, employing two methods (cyanide-resistant eosin-
ophil peroxidase-staining and transmission electron micros-
copy [TEM]) that otherwise well identify Cfegs (38). Also,
the intact eosinophils exhibited ultrastructural characteristics
of nonactivated eosinophils including dense granules and
smooth cell membranes in both Ig-deficient and wild-type
mice (this study). Rarity of epithelial eosinophils and lack
of clearly activated eosinophils may characterize also other
mice models of allergic asthma (39), but so far have re-
ceived little attention.
Abundance of PAS-positive epithelial cells in allergen-
challenged mice has been reported previously (40, 41) and
this feature was selected as one of the primary quantitative
indices of airway inflammation in the present study. We
could demonstrate dramatic increases in the number of air-
way epithelial mucus cells in the OVA/OVA-treated animals,
not least in the Ig-deficient mice. As evidenced by PAS-
positive material in the airway lumen, and as supported by
TEM observations, these cells were actively secreting in
both wild-type and Ig-deficient OVA/OVA-treated ani-
mals. Indeed, several small airways of the allergic animals
were occluded by the PAS-positive secretions. Such epi-
thelial changes may be the result of several nonspecific in-
flammatory mechanisms. However, the similarity in ap-
pearance of the present epithelial changes agree with the
possibility that allergic inflammatory processes may not dif-
fer greatly between wild-type animals and animals lacking
B cells and Ig. One potential cause of mucus cell genera-
tion is epithelial damage–repair processes. However, our
histological analysis revealed neither damage nor the occur-
rence of poorly differentiated repair cells in the epithelium
(see reference 42). In normal mice mucus-containing cells
are rare, although the common Clara cells occasionally may
contain PAS-positive granules (43). The possibility that
Clara cells may undergo transformation to the present mu-
cus cells, which are packed with PAS-positive granules,
now remains an attractive conjecture.
In conclusion, this study has demonstrated that immuni-
zation and allergen exposure-induced airway and pulmo-
nary eosinophilic inflammation develops in mice that lack
B cells and all Ig. These data challenge basic concepts of al-
lergic airway diseases and question the curative potential of
treatments aimed at inhibition of Ig and/or B cells.
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